ReutersReuters

Rua Bioscience Says Sales For Q1 FY26 Are A Record

RefinitivMeno di 1 minuto di lettura

Rua Bioscience RUA:

  • SALES FOR Q1 FY26 ARE A RECORD

  • RENOUCENABLE RIGHTS ISSUE OF 1 NEW SHARES FOR EVERY 3 EXISTING SHARES TO RAISE UP TO NZ$2MILLION

  • ISSUE PRICE UNDER RIGHTS OFFER NZ$0.025 PER SHARE

Accedi o crea un account gratuito per leggere queste notizie